ASPEN PHARMA IRELAND LIMITED NORWAY BRANCH

0191 OSLO

Finances

Share Ownership

Return on Equity

−1,27 %

Current Ratio

1,9

Debt-to-Equity Ratio

0,01

Key figures (EUR)	2022	2021	2020	2019
Revenue	210 244 000	4 546 000	429 633 000	420 002 000
Net Income	−1 718 000	379 000	−8 975 000	5 407 000
Total Assets	199 740 000	1 098 000	219 517 000	231 988 000
Total Equity	134 784 000	98 000	60 472 000	69 447 000

Income (EUR)	2022	2021	2020	2019
Revenue	210 244 000	4 546 000	429 633 000	420 002 000
Expenditure	207 529 000	4 252 000	93 302 000	84 840 000
Operating Profit	2 715 000	294 000	−6 858 000	9 679 000
Financial Income	85 000	170 000	0	0
Financial Costs	114 000	87 000	2 350 000	757 000
Financial Balance	−29 000	83 000	−2 350 000	−757 000
Earnings Before Tax	2 686 000	377 000	−9 208 000	8 922 000
Tax	4 404 000	−2 000	−233 000	3 515 000
Net Income	−1 718 000	379 000	−8 975 000	5 407 000

Balance (EUR)	2022	2021	2020	2019
Total Fixed Assets	78 418 000	183 000	3 515 000	721 000
Total Current Assets	121 322 000	915 000	216 002 000	231 267 000
Total Assets	199 740 000	1 098 000	219 517 000	231 988 000
Total Retained Equity	13 218 000	98 000	18 471 000	27 446 000
Total Equity	134 784 000	98 000	60 472 000	69 447 000
Total Long-Term Debt	998 000	0	2 080 000	427 000
Total Current Debt	63 958 000	1 000 000	156 965 000	162 114 000
Total Equity and Debt	199 740 000	1 098 000	219 517 000	231 988 000

Cash flow (EUR)	2022	2021	2020	2019
Sales Income	210 189 000	4 546 000	429 538 000	419 786 000
Other Income	55 000	0	95 000	216 000
Revenue	210 244 000	4 546 000	429 633 000	420 002 000
Cost of Goods Sold	171 934 000	0	0	0
Salary Costs	7 796 000	1 770 000	0	0
Depreciation	331 000	0	0	0
Impairment	1 981 000	0	0	0
Expenditure	207 529 000	4 252 000	93 302 000	84 840 000
Operating Profit	2 715 000	294 000	−6 858 000	9 679 000
Financial Income	85 000	170 000	0	0
Financial Costs	114 000	87 000	2 350 000	757 000
Financial Balance	−29 000	83 000	−2 350 000	−757 000
Dividends	8 000 000	0	0	0
Net Income	−1 718 000	379 000	−8 975 000	5 407 000

Balance details (EUR)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	820 000	169 000	294 000	309 000
Real Eastate	1 000	0	2 970 000	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	157 000	14 000	251 000	412 000
Total Tangible Assets	158 000	14 000	3 221 000	412 000
Total Fiancial Fixed Assets	77 440 000	0	0	0
Total Fixed Assets	78 418 000	183 000	3 515 000	721 000
Stock	34 840 000	0	79 013 000	90 878 000
Total Investments	0	0	20 051 000	17 857 000
Cash, Bank	5 304 000	479 000	16 046 000	15 376 000
Total Current Assets	121 322 000	915 000	216 002 000	231 267 000
Total Assets	199 740 000	1 098 000	219 517 000	231 988 000
Total Equity	134 784 000	98 000	60 472 000	69 447 000
Short-Term Group Debt	7 782 000	36 000	4 215 000	6 443 000
Total Long-Term Debt	998 000	0	2 080 000	427 000
Creditors	55 745 000	49 000	151 801 000	155 473 000
Unpaid Taxes	0	81 000	0	0
Dividends	8 000 000	0	0	0
Other Current Debt	431 000	751 000	949 000	0
Total Current Debt	63 958 000	1 000 000	156 965 000	162 114 000
Total Equity and Debt	199 740 000	1 098 000	219 517 000	231 988 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−1,27 %	386,73 %	−14,84 %	7,79 %
Debt-to-Equity Ratio	0,01	0	0,03	0,01
Operating Profit Margin	1,29 %	6,47 %	−1,6 %	2,3 %
Current Ratio	1,9	0,92	1,38	1,43
Quick Ratio	4,17	0,92	2,77	3,25
Equity Ratio	0,67	0,09	0,28	0,3
Gross Profit Margin	18,22 %	100 %	100 %	100 %